Presentation is loading. Please wait.

Presentation is loading. Please wait.

Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 

Published byMilton Rose Modified over 6 years ago

Similar presentations

Presentation on theme: "Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer "— Presentation transcript:

1 Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer  David J. Sher, M.D., M.P.H., Jon O. Wee, M.D., Rinaa S. Punglia, M.D., M.P.H.  International Journal of Radiation Oncology • Biology • Physics  Volume 81, Issue 5, Pages e767-e774 (December 2011) DOI: /j.ijrobp Copyright © 2011 Elsevier Inc. Terms and Conditions

2 Fig. 1 Markov model describing health states after treatment for early-stage non–small-cell lung cancer. 3D-CRT = three-dimensional conformal radiation therapy; NED = no evidence of disease; SBRT = stereotactic body radiotherapy; RFA = radiofrequency ablation. International Journal of Radiation Oncology • Biology • Physics  , e767-e774DOI: ( /j.ijrobp ) Copyright © 2011 Elsevier Inc. Terms and Conditions

3 Fig. 2 Acceptability curve. This curve represents the proportion of trials drawn on a hypothetical distribution of unknown parameters that result in an incremental cost-effectiveness ratio for stereotactic body radiotherapy (SBRT) less than the societal willingness to pay. Varied parameters include efficacy of three-dimensional conformal radiation therapy (3D-CRT), SBRT, and radiofrequency ablation (RFA), as well as utility values of no evidence of disease (NED) and recurrence health states. QALY = quality-adjusted life-year. International Journal of Radiation Oncology • Biology • Physics  , e767-e774DOI: ( /j.ijrobp ) Copyright © 2011 Elsevier Inc. Terms and Conditions

Download ppt "Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer "

Similar presentations

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.

Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy  Leena-Maija Aaltonen, MD,

Voice Quality After Treatment of Early Vocal Cord Cancer: A Randomized Trial Comparing Laser Surgery With Radiation Therapy  Leena-Maija Aaltonen, MD,
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012  Geoff P. Delaney,

The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012  Geoff P. Delaney,
Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.

Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:

Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy:
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,

Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,
Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc

Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc
Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D

Jerry D Slater, M. D. , Carl J Rossi, M. D. , Les T Yonemoto, M. D
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up  Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.

Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long- Term Follow-up  Bas Kreike, M.D., Augustinus A.M. Hart, M.Sc., Tony.
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials  Gustavo Arruda Viani,

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials  Gustavo Arruda Viani,
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases  Isabelle Thibault, MD, Mikki Campbell,
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma

Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer  Jeffrey L. Port, MD, Bhupesh Parashar,

Similar presentations

Ads by Google